Unveiling the Post-PKS Redox Tailoring Steps in Biosynthesis of the Type II Polyketide Antitumor Antibiotic Xantholipin  by Zhang, Weike et al.
Chemistry & Biology
ArticleUnveiling the Post-PKS Redox Tailoring Steps
in Biosynthesis of the Type II Polyketide
Antitumor Antibiotic Xantholipin
Weike Zhang,1 Lu Wang,2 Lingxin Kong,1 Tao Wang,1 Yiwen Chu,2 Zixin Deng,1 and Delin You1,*
1State Key Laboratory of Microbial Metabolism and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University,
1954 Huashan Road, Shanghai 200030, China
2Sichuan Industrial Institute of Antibiotics, Sichuan 610052, China
*Correspondence: dlyou@sjtu.edu.cn
DOI 10.1016/j.chembiol.2012.01.016SUMMARY
Xantholipin from Streptomyces flavogriseus is a
curved hexacyclic aromatic polyketide antitumor
antibiotic. The entire 52 kb xantholipin (xan) bio-
synthetic gene cluster was sequenced, and bio-
informatic analysis revealed open reading frames
encoding type II polyketide synthases, regulators,
and polyketide tailoring enzymes. Individual in-frame
mutagenesis of five tailoring enzymes lead to the
production of nine xantholipin analogs, revealing
that the xanthone scaffold formation was catalyzed
by the FAD binding monooxygenase XanO4, the
d-lactam formation by the asparagine synthetase
homolog XanA, the methylenedioxy bridge genera-
tion by the P450 monooxygenase XanO2 and the
hydroxylation of the carbon backbone by the FAD
binding monooxygenase XanO5. These findings
may also apply to other polycyclic xanthone antibi-
otics, and they form the basis for genetic engineering
of the xantholipin and similar biosynthetic gene clus-
ters for the generation of compounds with improved
antitumor activities.
INTRODUCTION
Polycyclic xanthone antibiotics feature an angular fused hexacy-
clic skeleton with a xanthone structure (orange in Figure 1). They
are active against fungal or Gram-positive bacteria, including
methicillin-resistant Staphylococcus aureus and vancomycin-
resistant Enterococcus faecalis (Peoples et al., 2008), or against
several cancer cell lines (Kunimoto et al., 2003). Xantholipin (1) is
a polycyclic xanthone antibiotic produced by Streptomyces
flavogriseus. It possesses potent cytotoxicity against the
leukemia cell line HL60 (IC50 < 0.3 mM) and the oral squamous
carcinoma cell line KB (IC50 < 2 nM; Terui et al., 2002), and it
was recently identified as a lead drug for the treatment of fibrotic
diseases (Yuichi et al., 2003). The total chemical synthesis of
another polycyclic xanthone antibiotic, FD-594, has been
achieved, but it required many steps and did not produce suffi-
cient amounts for medical testing (Masuo et al., 2009). Genetic
engineering of the gene cluster may be suitable for this purpose.422 Chemistry & Biology 19, 422–432, March 23, 2012 ª2012 ElsevieBiosynthetic studies and isotope-labeled precursor feeding
experiments of polycyclic xanthone antibiotics, including simao-
micin a, lysolipin I, and FD-594, proved that these molecules are
derived from a single polyketide chain, which is synthesized by
a type II polyketide (iterative) synthase (PKS) composed of three
monofunctional peptides (Bisang et al., 1999; Bockholt et al.,
1994; Carter et al., 1989; Kondo et al., 1998; Kudo et al., 2011;
Lopez et al., 2010). The polyketide chains then undergo various
post-PKS modifications to produce a variety of the polycyclic
xanthone antibiotics. Of particular interest are the formation of
the xanthone and the methylenedioxy bridge. Studies on lysoli-
pin I indicated that a Baeyer-Villiger (ketone/ ester) oxidation
is involved in the formation of the xanthone structure, because
the single xanthone oxygen originates from molecular oxygen.
Also, the two oxygens of the methylenedioxy group are from
molecular oxygen and the carbon 27 in between originates
from methionine (Bockholt et al., 1994). However, no microbial
enzymes for the formation of the two structure features have
been identified.
Here we report the cloning and sequencing of the entire
biosynthesis gene cluster of 1. Metabolite analysis of five
blocked pathway mutants identified a FAD binding mono-
oxygenase involved in the xanthone formation, a P450 mono-
oxygenase for the generation of the methylenedioxy bridge, an
asparagine synthetase homolog for amide ring formation, and
a putative polyketide hydroxylase for the C4 hydroxylation, re-
sulting in the proposal of a possible biosynthetic pathway for 1.
Additionally, we characterized two precursors of 1 chemically
and for their anticancer activities.RESULTS AND DISCUSSION
Identification, Cloning, and Sequencing of the xan Gene
Cluster and Determination of Its Boundaries
Xantholipin (1) is similar to lysolipin (LLP) for which the complete
biosynthesis gene cluster has been recently sequenced (Lopez
et al., 2010). Using conserved regions of the llpH halogenase,
we designed primers for the polymerase chain reaction (PCR)
amplification of a 300 bp fragment from S. flavogriseus, the
producer of 1. The predicted amino acid sequence of the PCR
fragment was 73% identical to that of LlpH, suggesting that
we may have amplified the halogenase gene, xanH, from
the xan gene cluster. These primers were then used to screen
a S. flavogriseus fosmid library (3,000 clones; 36 kb averager Ltd All rights reserved
Figure 1. Structures of Xantholipin and Derivatives
Orange, xanthone; blue, cyclic amide.
Chemistry & Biology
Tailoring Steps in Xantholipin Biosynthesisinsert size) using sib selection (McCormick, 1987). Sixteen over-
lapping fosmids were identified. To determine the relevance for
the biosynthesis of 1, a 40 kb DNA fragment was deleted from
the S. flavogriseus genome by gene replacement using the
remains of fosmid 28B8 after XhoI digestion and religation (Fig-
ure 2; Figure S1A available online). Two independently generated
mutants no longer produced 1, suggesting that the xan genes
may have been deleted (Figure S1D). Fosmid 22E4, containing
a central halogenase gene, was sequenced. It contained several
putative antibiotic tailoring genes but, surprisingly, no PKS
gene. Chromosomewalking using PCR probes 2 and 3 (Figure 2,
top) resulted in a minimal 92 kb contig flanked by fosmids
26G2 and 12A9. The 92,445 bp sequence contained 49 open
reading frames (ORFs) that were likely to be involved in the
biosynthesis of 1 (Figure 2 and Table 1). This was based on
functional assignment (XanY1–Y5) and the presence of likely
orthologs in the llp (lysolipin) and pnx (FD-594) gene clusters
(Kudo et al., 2011; Lopez et al., 2010). Deletion of ORF1–5 or
ORF6–9 from the S. flavogriseus genome produced normal
looking colonies that still produced 1 (Figures 2 and S1), indi-
cating that these ORFs were located outside the xan cluster.
Putative functions were assigned to most of the remaining 49
ORFs as shown in Figure 2 and Table 1. Six xan genes (black)
encode three cyclases (C1–C3) and a type II minimal PKS con-
sisting of the ketosynthase KSa (XanF), chain length factor
(CLF) KSb (XanE), and acyl carrier protein (ACP; XanD). Five
dispersed genes (green) were suspected for post-PKS tailoring:
a halogenase (XanH) for the chlorination of C12, an asparagine
synthetase homolog (XanA) for the formation of the amide ring,
two O-methyltransferases (XanM1 and XanM2) for the methyla-
tion of the C13 and C17 hydroxyl groups, and an additional
unassigned methyltransferase (XanM3). Consistent with the
highly oxidized structure of 1, 19 redox genes (pink and red)
were identified. In addition to the biosynthetic machinery, five
genes (xanY1–Y5, dark blue; not present in the llp and pnx
gene clusters) are for the S-adenosyl methionine (SAM) recy-
cling, and three genes (xanB1–B3, light blue; also without
orthologs in the llp or pnx clusters) are for the synthesis ofChemistry & Biology 19, 4malonyl-CoA extender units. There are also three putative
regulatory and three resistance genes (yellow) and five ORFs
without known functions (gray, xanJ, xanP, xanG, xanL, and
xanW), also without orthologs in the llp or pnx clusters.
Biosynthesis of the d-Lactam
Most polycyclic xanthones feature a cyclic amide, which is
otherwise rare among aromatic polyketides (blue in Figure 1;
FD-594 has a d-lactone instead). In addition, there are various
substituents on the amide nitrogen in the different polycyclic
xanthones, such as a methyl group in lysolipin, an amino group
in simaomicin, and more complicated heterocyclic structures
in citreamicin a and Kigamicin D. The xan gene cluster contains
an asparagine synthetase homolog, XanA, which strongly
resembles the class II asparagine synthetase homolog LlpA
(lysolipin) and the amide synthetase FdmV (Chen et al., 2010;
fredericamycin A, not a xanthone), including the conserved
active site and ligand binding site residues Arg50, Glu80,
Asp103, Ser264, and Gly376 (Larsen et al., 1999). FdmV has
been characterized to catalyze the formation of a hexacyclic
amide, which is similar to the amide ring of 1. XanA probably
converts the polyketide-derived C1 carboxyl group to an amide,
followed by the possibly spontaneous elimination of water to
form ring F (Figure 3, conversion of compound 8a to 9).
To test this hypothesis in vivo, xanA was replaced by an
apramycin resistance gene in the S. flavogriseus genome (Fig-
ure S1E). The DxanA mutant accumulated compound 8a
containing a chlorine and a xanthone structure but was devoid
of nitrogen (Figures 3 and 4). From 14 l fermentation broth,
85 mg of compound 8a was purified. ESI-Q-TOF MS, 1D and
2D nuclear magnetic resonance (NMR) spectra (1H, 13C, DEPT,
HMBC, HSQC), provided the molecular formula C26H19ClO9
and the structure (Figures 3, 4, S2, and S3). Different from our
expectation, there was no spontaneous cyclization producing
the a-pyrone derivative of 8a; instead, a carboxyl group re-
mained at C1, which was probably a more suitable substrate
for XanA. The purified compound 8a was then crystallized and
X-ray diffraction was performed to further confirm the position22–432, March 23, 2012 ª2012 Elsevier Ltd All rights reserved 423
Figure 2. The Organization of the Xantholipin Biosynthetic Gene Cluster
The gene cluster spans 52 kb and contains 49 ORFs. Genes are organized according to their proposed roles (see also Table 1); the underlined genes were
individually inactivated, except for orf1–5, orf6–9, and xanY3–Y5, which were deleted together. The 40 kb gray part of fosmid 28B8 is the region that was deleted
in strain ZWK1. The construction and verification of the deletion mutants are shown in Figure S1.
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chlorine bound to C12; surprisingly, a lactone derivative 8b
was generated during the crystallization of 8a from methanol
(Figures 3 and S2).
Since xanA is within a group of 14 genes that might form an
operon, inactivation of downstream genes by polar effects on
transcription might have contributed to the phenotype of the
DxanA mutant. Complementation expressing xanA from the
high copy vector pJTU1278 partially (40%) restored production
of 1 (Figure S1P), suggesting that deletion of xanA, and not inac-
tivation of a downstream gene, was responsible for the produc-
tion of 8a. Therefore, XanA was required for the amidation of 8a.
Bioinformatic Search for Genes for the Baeyer-Villiger
Oxidation
We next addressed the biosynthesis of the xanthone ring, which
is the characteristic feature of all polycyclic xanthone antibiotics
and has not been elucidated genetically before. Studies on lyso-
lipin I indicated that a Baeyer-Villiger oxidation was involved in
the formation of xanthone (Bockholt et al., 1994), and epoxida-
tion followed by a Baeyer-Villiger oxidation was proposed to
be involved in the xanthone formation of the polycyclic xanthone
antibiotic FD-594 (Kudo et al., 2011). Therefore, we selected four
redox enzymes (O2, O4, O5, and T), which had orthologs in the
FD-594 and lysolipin gene clusters, as possible candidates
that might catalyze these reactions or, as we found out later,
were involved in other steps for the biosynthesis of 1.
XanO4 was between 29% and 31% identical to the atypical
Baeyer-Villiger monooxygenases (BVMOs), including MtmOIV
(mithramycin), JadH (jadomycin), and GilOI (gilvocarcin), all of
which lack the typical sequence motif of type I BVMOs and are
not related to the type II BVMOs (Beam et al., 2009; Gibson
et al., 2005; Kharel et al., 2007; Rix et al., 2005). The similarities
included all three conservedmotifs (GxGxxG for binding the ADP
part of FAD, the sequence DG for binding the pyrophosphate of
FAD or NADPH, and GD for binding the riboflavin of FAD). XanO4
also resembled the atypical BVMO GrhO5 (42% identity) which,424 Chemistry & Biology 19, 422–432, March 23, 2012 ª2012 Elsevietogether with GrhO1, has been characterized through in vivo
experiments to catalyze three C-C bond cleavages for the forma-
tion of the spiroketal center of griseorhodin (Yunt et al., 2009).
Phylogenetic analysis of putative BVMOs showed two groups,
the type I BVMOs, and the atypical BVMOs, three of which
(XanO4, LlpOVIII, and PnxO4) were involved in the biosynthesis
of polycyclic xanthone antibiotics (Figure S4B). Interestingly,
these three proteins, together with GrhO5, formed a distinct
subgroup, separated from the group containingMtmOIV (mithra-
mycin). These sequence comparisons suggested that XanO4
may catalyze the formation of xanthone, using a mechanism
similar to that of the atypical BVMO GrhO5. However, no
homolog of GrhO1 was encoded in the xan cluster; therefore,
XanO4 may act alone or with other unidentified protein.
XanO2 was the only P450 monooxygenase in the xan gene
cluster. Several plant P450monooxygenases have been charac-
terized to catalyze the formation of methylenedioxy bridges
between amethoxy group and a nearby hydroxyl group (Ikezawa
et al., 2007; Ono et al., 2006). XanO2 was thus a candidate for
methylenedioxy bridge formation, except that FD-594, which
does not have a methylendioxy bridge, also contained P450
homologs. Alternatively, since many P450s catalyze epoxida-
tions (Guengerich, 2003), XanO2 might also catalyze the epoxi-
dation for xanthone formation.
XanO5 was similar to TcmG and GrhO9, which have been
proved to be involved in the tailoring hydroxylation of the
aromatic type II polyketide antibiotics tetracenomycin and
griseorhodin, respectively (Decker et al., 1993; Yunt et al.,
2009). XanO5 may thus be responsible for hydroxylating a
precursor of 1 or even be an alternative to XanO4 for xanthone
formation (XanO5 and XanO4 are 41% identical).
XanT, from the SchA/CurD superfamily, was conserved in the
three polycyclic xanthone antibiotic gene clusters but was rare
among the other aromatic PKS gene clusters. The only XanT
homolog was FdmK, which was proposed to be involved in
C-C bond cleavage for the formation of the spiro carbon
center of fredericamycin (Wendt-Pienkowski et al., 2005). XanTr Ltd All rights reserved
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ing they use the same cofactor. XanT was proposed to be the
partner protein supporting XanO4, but inactivation of xanT in
S. flavogriseus did not cause accumulation of 6 (see below).
S. Flavogriseus Mutant Derivatives Lacking Redox
Genes
The four genes xanO2, xanO4, xanO5, and xanT (Figure 2, under-
lined with black bars) had characteristics that suggest the likely
involvement in xanthone formation. They were deleted sepa-
rately in S. flavogriseus and replaced by an apramycin resistance
cassette (Figure S1). LC-MS showed that each of the four
mutants accumulated compounds that were different from 1
(Figure 4). Q-TOF MS was used to determine the molecular
formulae of the main components in each extract (Figures 4
and S3).
The XanO4 blocked mutant accumulated large amounts of
the red (483 nm) compound 6 (1 was yellow). By optimizing
the fermentation conditions and the isolation procedure, we
obtained 48.5 mg of 6 from a 7 l culture of the DxanO4 strain.
Evaluation of the 1H, 13C, DEPT, HMBC, HSQC NMR spectra
(Figure S2 and Table S1) produced the structure of 6 (Figure 3).
The NMR spectra resembled those of 8a, but the signals for
the ether bond of xanthone were missing, and a methoxylated
anthraquinone was identified instead. (Note that C15 of 6 is
replaced by O in 7.)
The DxanO2, DxanO5, and DxanT mutants produced insuffi-
cient amounts of compounds for NMR analysis, and it was
interesting to note that all of the three mutants accumulated
more than one product, which implied that the primary reaction
productswere probablymetabolized by other enzymes or under-
went spontaneous reactions. XanT and XanO4 probably acted
first, because the products from the deletion mutants did not
contain chlorine or nitrogen. XanO2 and XanO5 probably per-
formed late steps, because the accumulated products contained
one chlorine and one nitrogen, like compound 1 (Figures 3 and 4).
From the high-resolution molecular masses, the proposed
functions of XanO2 and XanO5 in the biosynthetic pathway of 1
(see above), and the structures of 8a/8b and 1, compounds
11a (accumulated by theDxanO2mutant) and 15a (accumulated
by the DxanO5 mutant), probably had the structures shown in
Figure 3. Structure 7 was proposed from the comparison of
the known structures 6 and 8a/8b, and 9 was proposed from
the comparison between 8a/8b and 1. The proposed structures
of the other compounds are explained below.
Introducing an integrative plasmid expressing xanO2 from
the ermE* promoter (McDaniel et al., 1993) into the DxanO2
mutant only partially restored 1 production (Figure S1Q),
possibly because the promoter was not suitable for XanO2
expression in S. flavogriseus or because the expression of the
downstream xan genes was reduced.
XanO4 was purified from an E. coli clone. In the presence of
XanO4, it oxidized NADPH to NADP and transferred the elec-
trons to FAD. Compound 6, the proposed substrate of XanO4,
was not converted to compound 7 using NAD(P)H and FAD as
cofactors (Figure S5). Therefore, XanO4 probably requires
a partner protein to convert 6 to 7. Unfortunately, XanT, the
proposed partner protein of XanO4 (see above), could not be
obtained in soluble form for enzymatic testing.Chemistry & Biology 19, 4Bioactivity of Xantholipin and Putative Biosynthetic
Intermediates
To determine how the oxidative modification during 1 biosyn-
thesis affects bioactivity, we performed in vitro cytotoxicity
assays of 6, 8a, 1, and doxorubicin as a positive control. Table
2 shows that 1 was 10-fold more effective against a lung cancer
cell line, 3-fold more effective against a colon cancer cell line,
and equally effective against a leukemia than the commonly
used anticancer drug doxorubicin. The precursors 6 and 8a
were, however, about 102- to 103-fold less potent. These data
indicated that the post-PKS modifications were important for
bioactivity.
Proposal for a Biosynthetic Pathway for 1
The proposed biosynthesis pathway of 1 (Figure 3) probably
begins with the synthesis of malonyl-CoA from carboxylation of
acetyl-CoA by the enzymes XanB1–B3 (probable acetyl-CoA
carboxylase; Figure 2, light blue arrows; Table 1). These
enzymes probably duplicate enzymes from the primary metabo-
lism, which supply malonyl-CoA for fatty acid biosynthesis.
Similar clusters occur in other antibiotic biosynthesis gene clus-
ters, including that of pradimicin (Kim et al., 2007), but interest-
ingly, there are no orthologs in the llp and pnx gene clusters.
Condensation of 13 malonate units by the minimal type II PKS
(XanDEF; acyl carrier protein, ACP; chain length factor, CLF or
KSb; ketosynthase, KSa) probably produces the hypothetical,
enzyme-bound, and fully oxidized polyketide 2. The three PKS
subunits contained all the conserved active-site residues (Bi-
sang et al., 1999). A phylogenetic analysis of KSbs of type II
PKSs showed that, as expected for the C26 polyketide chain
of 1, XanE clustered with the longer chain (C24–30) KSbs (Fig-
ure S4A). Unusual for type II PKS gene clusters, including llp
and pnx, xanD (ACP) was separate from the KS genes.
Three carbonyl reductions at C11, C17, and C19 were postu-
lated to produce the hypothetical compound 3, based on
isotope-feeding experiments of lysolipin and citreamicin (Guy
et al., 1991). They are probably performed by the 3-oxoacyl-
ACP reductases XanZ3 and XanZ4, which have orthologs in
the llp and pnx gene clusters (about 70% identity) and are similar
to the characterized C19 ketoreductase (KR) BenL (benastatin;
Lackner et al., 2007). C19 KRs are known exclusively from angu-
cycline antibiotics, and usually there is only a single C19 KR in
each cluster (Lackner et al., 2007). The xan, llp, pnx, and grh (gri-
seorhodin) gene clusters encode two probable C19 KRs, which
were different from most angucycline antibiotic gene clusters
(Li and Piel, 2002). Since no C11 KR has been, to our best knowl-
edge, reported before, a phylogenetic analysis of the C17 KRs
and the C19 KRs was performed. It revealed that XanZ3 clus-
tered with LlpZI, PnxG, GrhT, GrhO10, and known C19 KRs
and XanZ4 clustered with LlpZIII and PnxW but not with known
C17 KRs (Xu et al., 2005; Figure 5). XanZ3 was thus the likely
C19 KR, and XanZ4, LlpZIII, and PnxW may belong to a new
family of C11 KRs, which are exclusive to polycyclic xanthone
antibiotics.
Guided by the C11 and C19 hydroxyl groups, the cyclases
XanC1–C3 then form five C-C bonds (intramolecular aldol
condensations) to form the angular 5-ring aromatic structure 4.
XanC1 resembled the first and second ring cyclase TcmN (tetra-
cenomycin; McDaniel et al., 1995; Shen and Hutchinson, 1996).22–432, March 23, 2012 ª2012 Elsevier Ltd All rights reserved 425
Table 1. Deduced Functions of ORFs in the Xantholipin Biosynthetic Gene Cluster
Xan Proteins Protein Homologs
Gene (aa) Proposed Function Protein, Origin Identity/Similarity (%)
xanY1 (472) Adenosylhomocysteinase SSDG_05037, S. pristinaespiralis 95/97
xanY2 (300) Methylenetetrahydrofolate reductase SSDG_05038, S. pristinaespiralis 84/89
xanY3 (1165) Methionine synthase SSCG_05781, S. clavuligerus 89/93
xanY4 (330) Carbohydrate kinase SsfX2, S. sp. SF2575 70/79
xanY5 (406) SAM synthetase SSCG_03814, S. clavuligerus 85/91
xanO1 (145) Monooxygenase SanK, S. sp. SANK 61196 33/51
xanS1 (407) Dehydrogenase LlpS, S. tendae 59/74
xanJ (242) Unknown ORF6, S. antibioticus 42/56
xanP (539) Unknown SBI_09782, S. bingchenggensis 69/78
xanG (391) Unknown LlpG, S. tendae 60/71
xanA (614) d-lactam formation LlpA, S. tendae 72/80
xanR1 (227) Transcriptional regulator LlpRIII, S. tendae 49/61
xanO2 (400) Cytochrome P450 LlpOIV, S. tendae 73/84
xanK (89) 3Fe-S ferredoxin LlpK, S. tendae 67/77
xanU (709) Antibiotic transporter ORF27, S. globisporus 57/73
xanO3 (392) FAD-binding monooxygenase Krac_4468, Ktedonobacter racemifer 44/59
xanL (186) Unknown BSG1_19969, Bacillus sp. SG-1 33/52
xanH (471) Halogenase LlpH, S. tendae 70/85
xanQ (533) Transporter FdmT, S. griseus 46/60
xanM1 (339) O-methyltransferase LlpMIV, S. tendae 63/72
xanZ1 (285) Reductase LlpZII, S. tendae 59/73
xanN (431) Antiporter Veg3, uncultured soil bacterium 57/76
xanW (162) Unknown SACTE_4627, S. sp. SirexAA-E 48/67
xanR2 (153) Transcriptional regulator PnxR1, S. sp. TA-0256 34/53
xanM2 (340) O-methyltransferase LlpMIII, S. tendae 63/74
xanO4 (540) FAD-binding monooxygenase LlpOVIII, S. tendae 70/81
xanM3 (344) O-methyltransferase LlpMII, S. tendae 64/77
xanO5 (531) FAD-binding monooxygenase GrhO9, S. sp. JP95 43/58
xanS2 (228) Dehydrogenase LlpU, S. tendae 56/69
xanZ2 (302) Oxidoreductases SSAG_00456, S. sp. Mg1 80/87
xanR3 (335) Transcriptional regulator SACTE_0424, S. sp. SirexAA-E 83/87
xanB1 (447) Biotin carboxylase PdmP1, Actinomadura hibisca 63/74
xanB2 (174) BCCP PdmP2, Actinomadura hibisca 51/59
xanB3 (564) Carboxyl transferase ZhuF, S. sp. R1128 59/68
xanO6 (103) Monooxygenase LlpOII, S. tendae 59/68
xanO7 (115) Monooxygenase LlpOIII, S. tendae 58/71
xanZ3 (250) 3-oxoacyl-ACP reductase LlpZI, S. tendae 70/83
xanO8 (153) Monooxygenase LlpB, S. tendae 65/77
xanC1 (155) Cyclase RubF, S. collinus 68/78
xanE (428) Chain length factor LlpE, S. tendae 68/77
xanF (425) Ketosynthase LlpF, S. tendae 80/89
xanC2 (144) Cyclase LlpCII, S. tendae 72/84
xanT (128) CurD homolog LlpT, S. tendae 71/84
xanO9 (472) Oxidase Aur2I, S. aureofaciens 47/62
xanO1 (148) Monooxygenase LlpQ, S. tendae 61/72
xanV (126) CurD homolog LlpV, S. tendae 72/84
xanZ4 (251) 3-oxoacyl-ACP reductase LlpZIII, S. tendae 66/75
xanD (86) ACP SsfC, S.sp. SF2575 48/67
xanC3 (112) Cyclase LlpCIII, S. tendae 69/84
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Table 1. Continued
Xan Proteins Protein Homologs
Gene (aa) Proposed Function Protein, Origin Identity/Similarity (%)
orf1 (71) AbaA-like protein SGR_1054, S. griseus 85/97
orf 2 (286) DNA-binding SGR_1055, S. griseus 83/89
orf 3 (163) Regulatory protein SGR_1056, S. griseus 51/65
orf 4 (543) Unknown SGR_1057, S. griseus 64/72
orf 5 (97) Unknown SGR_880, S. griseus 54/73
orf 6 (647) Ketoacyl-ACP synthase PctM, S. pactum 44/53
orf 7 (462) Acyl-CoA synthetase KRH_03520, Kocuria rhizophila 34/51
orf 8 (566) Acetolactate synthase Trd_0894, Thermomicrobium roseum 35/46
orf 9 (220) Ketoacyl-ACP synthase PctM, S. pactum 45/61
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in 1. XanC3 was very similar to TcmI and JadI (jadomcyin), which
have been proved to be responsible for ‘‘kinked ring’’ cyclization
(Shen and Hutchinson, 1993), and may thus form the bond
between C4 and C21 for ring E of compound 4. XanC2 resem-
bled several cyclases (RubD, GrhS, FdmD, and TcmJ), whichFigure 3. Proposed Xantholipin Biosynthetic Pathway
Black underline, structure confirmed using NMR or X-ray crystallography as show
chemical change. See also Figure S6.
Chemistry & Biology 19, 4may increase the yields of cyclized products by stabilizing the
complex composed of the minimal PKS (Bao et al., 1998). There
are no clues about which enzymes may perform the third and
fifth cyclizations to form compound 4.
Based on the proven structure of compound 6 (see below), the
pentacyclic compound 4 needs to undergo three hydroxylationn in Figure S2; black triangle, gene deleted in producer strain; shading, latest
22–432, March 23, 2012 ª2012 Elsevier Ltd All rights reserved 427
Figure 4. Analysis of Antibiotic Production by S. Flavogriseus and Its
Mutant Derivatives
Top, UV spectra of compounds 1 (xantholipin, yellow), 6 (red), and 8a (yellow).
Bottom, HPLC traces (274 nmUV absorption). The formulas of the compounds
were given byQ-TOFMass shown in Figure S3. Note, 8bwas generated during
the crystallization from methanol for X-ray analysis.
See also Figure S5.
Table 2. Antitumor Activity of Xantholipin Precursors
Tumor
Cell
Lines
IC50 (ng/ml)
Doxorubicin Xantholipin 6 8a
A-549
(lung)
266 ± 46 21 ± 2 3,900 ± 300 8,900 ± 600
HCT-116
(colon)
27 ± 7 7 ± 1 6,700 ± 1,000 11,900 ± 1,400
P388
(leukemia)
11 ± 1 11 ± 1 >20,000 20,000 ± 7,000
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anthraquinone structure of 5, which was probably no longer
attached to the ACP. Aromatic type II PKS gene clusters,
including xan, do not contain a thioesterase, and it is not known
how the molecules are released from the ACP (Staunton and
Weissman, 2001).
Four small putative antibiotic biosynthesis monooxygenase
(ABM) superfamily enzymes, XanO6, XanO7, XanO8, and
XanO10, were predicted to be associated with the hydroxyl-
ations of the aromatic backbone. XanO8 was similar to FdmM
(48% identity), which has been characterized to hydroxylate
C6 nearest to the inside bend of fredericamycin (Chen et al.,
2009), which corresponds to position C6 in 5. Therefore,
XanO8 probably hydroxylates C6. XanO6 and XanO7 were
similar to PdmH, which has been proved to be responsible for
quinone formation in the pentangular polyphenol backbone of
pradimicin (Zhan et al., 2008). XanO10 was similar to FdmM1
(48% identity) hydroxylating C8 in fredericamycin (Chen et al.,428 Chemistry & Biology 19, 422–432, March 23, 2012 ª2012 Elsevie2009). The two reactions both correspond to the oxidation at
C8 in 5. XanO6, XanO7, and XanO10 were thus candidates for
the hydroxylation at C8 in 4. The oxidation of 4 at C17 may
also be performed by one of the three enzymes.
An additional gene, xanT (SchA/CurD superfamily), also
encodes a small protein similar to ABM monooxygenase and
has homologs in the llp and pnx clusters. XanT was the possible
enzyme that supports XanO4 in the formation of the xanthone
structure. Inactivation of xanT resulted in the accumulation of
a new metabolite 16 but did not abolish 1 production (Figure 4).
Q-TOF analysis revealed that 6 and 16 contained the same
number of carbons but 16 lacked an oxygen (Figure S3), sug-
gesting that XanT acted on a less oxidized precursor of 6 before
the xanthone was synthesized. The residual production of 1 in
these mutants might have resulted from nonspecific activities
from unidentified endogenous enzymes.
One of the three putative S-adenosyl-L-methionine-depen-
dent methyltransferases (SAM-MTases; XanM1, 2, or 3) then
transfers a methyl group to the C17 hydroxyl group of 5 to
produce 6, which was accumulated by the DxanO4 mutant
(see above). The hypothetical compound 10 contains two
methoxy groups. XanM1 and XanM2 resembled O-methyltrans-
ferases, and XanM3 contains motifs for O- and C-methyltrans-
ferases. XanM1 and XanM2 were thus likely to be involved in
the methylation of the C13 and C17 hydroxyl groups. The fully
characterized compounds 6 and 8a were O-methylated at C17
but not at C13. The C13 O-methylation may thus be specific
for the hypothetical compound 9, which contains the chlorinated
xanthone and the d-lactam.
XanY1–Y5, encoded by successive genes on the left side of
the xan cluster, are a complete set of enzymes for the recycl-
ing of S-adenosylhomocysteine (a by-product in the SAM-
dependent methylation reaction) to SAM (Haagen et al., 2006).
These five genes are presumably required to ensure the supply
of sufficient SAM precursor for the two methylations during the
late growth phase, as has been proposed for saframycin biosyn-
thesis (Li et al., 2008). Inactivation of XanY3-Y5 decreased the
production of 1 about two-fold, which might have been caused
by the insufficient supply of the methyl group from SAM (Fig-
ure S1). The residual 1 production probably utilized SAM from
the primary biosynthetic pathway.
XanO4, probably together with an unidentified protein, cata-
lyzes xanthone formation resulting in 7 because deletion of
XanO4 resulted in the accumulation of 6 (see above). GrhO1
and GrhO5 (similar to XanO4) act together to catalyze three
carbon-carbon bond cleavages for the biosynthesis of ther Ltd All rights reserved
Figure 5. Phylogenetic Analysis of the XanZ3,
XanZ4, and Their Homologs
PDB ID codes: LlpZI, CAM34340; GrhO10, AAM33668;
RubG, AAG03071; BenL, CAM58804; FdmO, AAQ08926;
SanO, ADG86325; PnxG, BAJ52686; LlpZIII, CAM34370;
PnxW, BAJ52708; ChaL, CAH10174; AknU, AF264025;
DnrH, AAA65202; FabG, EGT67884.
See also Figure S4.
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Tailoring Steps in Xantholipin Biosynthesisspiroketal polyketide griseorhodin (Yunt et al., 2009). A two
enzyme mechanism, including the XanO4 homolog PnxO4,
was proposed for the xanthone ring formation for FD-594
(Kudo et al., 2011). Biosynthesis of the other polycyclic xanthone
antibiotic lysolipin may thus also implicate a two component
system, including the XanO4 homolog LlpOVIII to form the
xanthone structure.
The mechanism of xanthone formation remains uncertain.
XanO4 may cleave the C14-C15 or the C15-C16 bond. We
proposed two alternative paths for the formation of the xanthone
scaffold from 6 (Figure S6). The two paths share a Baeyer-Villiger
oxidation catalyzed by XanO4, converting the quinone of 6 to
a lactone via a ‘‘Criegee’’ intermediate. After that, the lactone
may undergo a second round of Baeyer-Villiger oxidation, and
the resultant circular carbonate ester is formed, followed by
a decarboxylation reaction to produce 7 (path A). Alternatively,
the lactone is hydrolyzed and recyclized via an intramolecular
OH-attack. The resultant intermediate is hydroxylated at C7 fol-
lowed by a decarboxylation and dehydration to yield 7 (path B).
In both cases some additional, unidentified protein or cofactor
may be required for the reaction.
Chlorination of 7 at C12 by XanH produces 8a, which was fully
characterized. XanH, the only putative halogenase of the xan
gene cluster was 70% identical to LlpH (lysolipin biosynthesis),
which is a nonheme, flavin-dependent halogenase (Lopez
et al., 2010). Enzymes in this class catalyze the formation of
carbon-halogen bonds at electron-rich positions, using FADH2,
a halide ion (usually Cl), and molecular oxygen (Yeh et al.,
2007). The reduced flavin is provided by a partner flavin reduc-
tase, which could not be located within the sequenced 92 kb
region. XanH seemed to be specific for 7 containing the
xanthone structure, because it did not chlorinate 6 in theDxanO4
mutant.
The next step is the d-lactam (ring F) formation by the amide
synthetase XanA (resembled asparagine synthetase; see above).
Inactivation of XanA accumulated an expected carboxylic acidChemistry & Biology 19, 422–432, March 238a and the trans-complementation restored 1
biosynthesis. This indicated that XanA was
most probably required for the incorporation of
the nitrogen and the formation of the character-
istic d-lactam ring to produce 9. Compound 6,
that accumulated in the DxanO4 mutant, was
not amidated by XanA, suggesting that the
xanthone structure, the chlorine or both may
be important for XanA activity (Figure 3). This
was in line with FdmV (fredericamycin), which
can utilize a wide range of nitrogen sources
but is specific for the fredericamycin precursor
(Chen et al., 2010). Multiple alignments ofFdmV homologs revealed that the Cys2, which is indispensable
for glutaminase activity, was mutated to Ser in PdmN (pradimi-
cin) and GrhP (griseorhodin), implying that their ability to hydro-
lyze Gln was lost (Chen et al., 2010). In the case of PdmN, L-Ala
was still used as a nitrogen source instead of free NH3 (Kim et al.,
2007). The putative amide synthetases for citreamicin and
kigamicin D feature the C2S mutation and may utilize unusual
amino acids to form the heterocyclic structures.
C13 O-methylation by XanM1 or XanM2 produces 10, which
is then hydroxylated at C19 to produce 11a. The identity of the
oxidase for the C19 hydroxylation of 10 remains uncertain.
Bioinformatic analysis and the gene replacement experiment
(see above) suggested that XanO2, the only P450 monooxyge-
nase in the xan gene cluster, may convert 11a to 12 (methylene-
dioxy bridge formation). Small amounts of a compound with the
same formula as 11a (calculated 522.0950, observed 522.0933,
resulting in the same formula) was isolated from the DxanO2
mutant. Two other compounds, 11b and 11c, with a UV absorp-
tion similar to compound 8a (380nm), were probably shunt
products derived from 11a with added H2 or H2O, respectively.
Their structures were not characterized by NMR because of
insufficient yield. Compound 11a was a suitable substrate for
methylenedioxy bridge formation. Considering all the informa-
tion above, XanO2 probably catalyzed a reaction between the
C19 hydroxyl group and the C17 methoxy group to form the
methylenedioxy bridge of 12.
Biochemical logic suggested that four steps are needed to
convert 12 to 1; hydroxylation of 12 at C22, followed by formation
of the quinone ring E and reduction of the C4-C21 double bond
results in 15a, which was the predicted substrate for C4
hydroxylation.
Hydroxylation at C22 of 12 is similar to the three earlier hydrox-
ylations at C6, C8, and C17 of 4 and was proposed to come after
the methylenedioxy bridge formation by XanO2. Analysis
mentioned above assigned four possible candidate enzymes
for the three hydroxylations. One of the four putative, 2012 ª2012 Elsevier Ltd All rights reserved 429
Chemistry & Biology
Tailoring Steps in Xantholipin Biosynthesismonooxygenases, XanO6, 7, 8, or 10, may perform this step.
No enzyme has been identified for the formation of quinone
in ring E.
Prior to the C4 hydroxylation, the double bond between C4
and C21 has to be reduced. Two reductases, other than the
3-oxoacyl-ACP reductase, XanZ1 and XanZ2, are encoded in
the xan cluster. XanZ1 is homologous to a F420-dependend
reductase and XanZ2 belongs to the aldo/keto reductase super-
family, who use soluble NAD(P)H as electron donor. It is still
uncertain which one of the two reductases is responsible for
the reduction of the C4-C21 double bond in the conversion of
14 to 15a.
Compound 15a, accumulated by the DxanO5 (polyketide
hydroxylase) mutant, possibly has the expected substrate
structure for C4 hydroxylation. Compounds 15b and 15c
were likely shunt products derived from 15a, with added H2 or
H2O. Thus, XanO5, was most probably responsible for the C4
hydroxylation of 15a to complete the biosynthesis of 1.
SIGNIFICANCE
Xantholipin is a polycyclic xanthone antibiotic representing
a class of molecules exhibiting antitumor, antibacterial,
and antifungal bioactivity. The biosynthetic pathways for
these compounds are of great interest, as they undergo
uncommon prearomatic modifications and reveal unusual
functional groups. We have identified the biosynthetic
gene cluster and its boundaries, which features an unusual
C11 ketoreductase for the pre-aromatic reduction of the
tridecaketide backbone of xantholipin. We also obtained
nine compounds accumulated by blocked pathwaymutants,
two of which were fully characterized. This gave insight
into the biosynthesis of three main structural features of
xantholipin, including a FAD binding monooxygenase for
the xanthone scaffold, an amide synthetase for the amide
bond formation, and, to our knowledge, the first identifica-
tion of a bacterial P450 monooxygenase for methylenedioxy
bridge formation. Characterization of the biosynthetic
pathway of xantholipin provides the opportunity to under-
stand unusual modifications involved in the biosynthesis of
polycyclic xanthone antibiotics and generate libraries of
derivative compounds for structure-activity relationship
studies by genetic engineering.
EXPERIMENTAL PROCEDURES
Bacteria Strains, Plasmids, Primers, Culture Conditions,
and General Techniques
Bacterial strains and plasmids are listed in Table S1, primers are in Table S2.
Escherichia coli DH10B, BW25113, and ET12567/pUZ8002 were used for
cloning, l-Red-mediated recombination or, conjugation between E. coli
and Streptomyces spp., respectively (Gust et al., 2003; Paget et al., 1999).
S. flavogriseus SS101 was the wild-type xantholipin producer used for the
generation of mutant strains. ISP-3 solid medium was used for S. flavogriseus
sporulation and SFM solid medium (Kieser et al., 2000) for conjugation
between E. coli and Streptomyces. Liquid seed medium (per liter: 10 g
glucose, 25 g soluble starch, 2 g yeast extract, 5 g fishmeal, 3 g pharmamedia,
3 g casein, and 2 g calcium carbonate [pH 7.2]) was used for growing mycelia
for the isolation of total DNA and liquid fermentation medium (per liter: 20 g
oatmeal, 10 g pharmamedia, 5 g fish meal, 10 g glucose, 25 g dextrin, 2 g
yeast extract, and 3 g calcium carbonate [pH 7.2]) was used for xantholipin430 Chemistry & Biology 19, 422–432, March 23, 2012 ª2012 Elsevieproduction. For Streptomyces, thiostrepton and apramycin were used at
12.5 mg/ml and 15 mg/ml in solid and liquid media, respectively.
The unstable Streptomyces plasmids pHZ1358 (Sun et al., 2009) and its
derivative plasmid pJTU1278 were used for gene inactivation. pMD18-T
(TaKaRa, Dalian, China) and pBlueScript II SK(+) (Stratagene, La Jolla, CA,
USA) were used for DNA sequencing, and pRSET B (Invitrogen, Shanghai,
China) was used for heterologous protein expression. Recombinant DNA
techniques for E. coli and Streptomyces were as described (Kieser et al.,
2000; Sambrook and Russell, 2000).
S. Flavogriseus Fosmid Library
A library of S. flavogriseus DNA in E.coli EPI300-T1R was constructed in the
vector pCC1FOS using CopyControl Fosmid Library Production Kit (Epicenter,
Madison, WI, USA). Conservedmotifs of nonheme halogenases involved in the
biosynthesis of lysolipin were identified by sequence alignment and used to
design the PCR primers probe1-F/R. The fosmid library was screened by
PCR and fosmid 22E4 was isolated. Two more primer pairs, (probe2-F/R,
probe3-F/R) were used to isolate fosmids 26G2 and 12A9, which cover the
entire xantholipin biosynthesis gene cluster (Figure 2).
Replacements in S. Flavogriseus
To genetically inactivate the putative xantholipin gene cluster, fosmid 28B8
was completely digested by XhoI and religated to give pJTU3923, which lacks
40 kb from xanU to orf9 (Figure 2, open box). Then a 3.0 kb BamHI fragment
from pJTU3923, containing the remains of 28B8, was cloned into the BamHI
site of pBlueScriptII SK(+) to give pJTU3852. A 1.4 kb fragment containing
aac(3)IV was amplified from pHGF9827 using primers ZWK1-F/R and inserted
into the unique XhoI site of pJTU3852 to produce pJTU3851. Subsequently,
the 4.4 kb BamHI fragment from pJTU3851 was inserted into the BamHI site
of the unstable Streptomyces vector pJTU1278 to give the 40 kb fragment
deletion vector pJTU3853, which was then introduced into S. flavogriseus by
conjugation to generate mutant ZWK1 by double crossover (Figure S1A).
PCR using primers ZWK1-DF/DR confirmed the deletion (not shown). The
determination of the boundaries of the xan cluster and construction of
individual gene inactivation mutants is described in detail in Figure S1 and
the Supplemental Experimental Procedures.
Analysis of Xantholipin Metabolites
S. flavogriseus was grown for six days in fermentation medium at 30C,
collected by centrifugation and extracted overnight with n-butanol. The
supernatant was collected by centrifugation, dried under reduced pressure
and dissolved in methanol. The methanol extract was analyzed by LC-MS
(Agilent 1100 series LC/MSD Trap system, Agilent, Santa Clara, CA, USA).
The HPLC was operated at a flow rate of 0.5 ml/min on a Waters SB-C18
(3.9 3 150 mm, 2 mm) column. Solvent A was 0.2% formic acid and 0.1%
TFA, solvent B was acetonitrile. The program used a gradient from 20 to
55% solvent B over 50 min. The elution was monitored at 274 nm and
analyzed using the Waters Millennium Chromatography Manager (Agilent).
The ion trap mass spectrometer was operated in the positive ion mode. Drying
gas flow was 8 l/min, and nebulizer pressure was 206.8 kPa. Drying gas
temperature was 325C, and the fragmentation was between 1.0 V to 1.8 V.
An Agilent 6530 Accurate-Mass Q-TOF LC/MS was used for high-resolution
mass measurements.
Production, Isolation, andCharacterizationofCompounds6and8a/b
Compounds 6 and 8a were produced, isolated, and analyzed using method
similar to each other. First, the two mutant strains S. flavogriseus ZWK8 and
ZWK2were grown at 30C in 7 l and 14 l of fermentation medium, respectively;
each 10 l fermenter contained 7 l culture. After six days, the mycelia were
harvested by centrifugation and the compounds were extracted from the
mycelium by 7 l and 10 l of methanol, respectively. The extract was then
evaporated to 2 l, and the remaining liquid was re-extracted by 2 l of ethyl
ethanoate. Then the organic phase was concentrated and fractionated by
silica gel column chromatography (chloroform/methanol, gradient elution).
Fractions containing the target compound were combined, dried, and further
purified by preparative LC (C18 column, 40%–60% methanol in H2O over
10 min for 6, 50%–80% methanol in H2O over 10 min for 8a). Final purification
was accomplished by preparative HPLC (C18 column, gradient for 6; 30 tor Ltd All rights reserved
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30% to 80% acetonitrile, [pH 3.5] H2O with acetic acid over 15 min). We
obtained 48.5 mg of 6 and 84.5 mg of 8a.
The structures of 6 and 8a were characterized using 1H, 13C NMR, DEPT,
HSQC, HMBC (Table S1). Single crystals of 8bwere prepared by recrystalliza-
tion in methanol, and the X-ray analysis was accomplished at the Shanghai
Institute of Organic Chemistry.
Expression, Purification, and Analysis of the BVMO XanO4
For the heterologous expression of XanO4 in E. coli BL21(DE3)/pLysE/
pJTU3889 (pRSET B containing xanO4), a BamHI-EcoRI fragment was
amplified from genomic DNA using primers XanO4-F/R (Tables S2 and S3).
The transformants were grown in 1 l of LBBS (per liter: 10 g trptone, 5 g yeast
extract, 10 g sodium chloride, 185.9 g D-sorbitol, and 0.31 g betaine) medium
containing ampicillin and chloramphenicol at 37C to A600 0.6 before addition
of isopropy-b-D-thiogalactoside (IPTG) to 0.2 mM, followed by incubation
at 18C for 24 hr. His6-XanO4 was absorbed to a 1 ml HisTrap HP column
(GE Healthcare) and eluted at 1 ml/min1 by a gradient of imidazole from
5 mM to 500 mM over 30 min in 150 mM NaCl and 20 mM Tris-HCl (pH 7.9)
using the Amersham Biosciences A¨KTA FPLC.
XanO4-catalyzed oxidation of NADPH was monitored at 30C at 340 nm, in
50 mM PBS (pH 7.5), containing 0.5 mM NADPH, 0.2 mM FAD, 40 mM XanO4,
and 80 mM 6.
Bioactivity Assays
Cell proliferation was determined using the methyl thiazolyl tetrazolium (MTT)
assay for A-594, HCT-116, and P388 cells. Two thousand cells in 100 ml media
per well were placed in a 96-well plate and allowed to incubate overnight
at 37C. Then, six different concentrations of xantholipin, 6, or 8a in DMSO
were added to the cells in triplicate. After 72 hr, 20 ml 5 mg ml1 MTT was
added. After 3 hr, the supernatant was removed and 100 ml DMSO was
added to each well. Cell proliferation was assayed colorimetrically using a
SpectraMAX340 comparing 550 nm and 690 nm absorptions. All cells were
cultured according to ATCC or DSMZ guidelines. Prism (GraphPad) was
used for analysis.
Phylogenetic Analysis
Multiple sequences were aligned using ClustalW (Thompson et al., 1994), and
the phylogenetic trees were generated by MEGA (version 3.1; Kumar et al.,
2004) using neighbor-joining with Poisson correction and 1,000 replicate
bootstrap analysis. The sequence of E. coli FabG was used as an outgroup
to root the tree in Figure 5. To validate the tree topology, minimum evolu-
tion was also used as a distance method. Both methods gave similar tree
topologies.
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